JP2012239697A - 人工骨膜 - Google Patents
人工骨膜 Download PDFInfo
- Publication number
- JP2012239697A JP2012239697A JP2011113498A JP2011113498A JP2012239697A JP 2012239697 A JP2012239697 A JP 2012239697A JP 2011113498 A JP2011113498 A JP 2011113498A JP 2011113498 A JP2011113498 A JP 2011113498A JP 2012239697 A JP2012239697 A JP 2012239697A
- Authority
- JP
- Japan
- Prior art keywords
- bmp
- artificial periosteum
- biodegradable polymer
- coli
- sheet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000006735 Periostitis Diseases 0.000 title claims abstract description 34
- 210000003460 periosteum Anatomy 0.000 title claims abstract description 34
- 239000000463 material Substances 0.000 claims abstract description 40
- 108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 claims abstract description 14
- 102100024506 Bone morphogenetic protein 2 Human genes 0.000 claims abstract description 14
- 108010049870 Bone Morphogenetic Protein 7 Proteins 0.000 claims abstract description 8
- 102100022544 Bone morphogenetic protein 7 Human genes 0.000 claims abstract description 8
- 108010049955 Bone Morphogenetic Protein 4 Proteins 0.000 claims abstract description 4
- 108010049976 Bone Morphogenetic Protein 5 Proteins 0.000 claims abstract description 4
- 108010049974 Bone Morphogenetic Protein 6 Proteins 0.000 claims abstract description 4
- 102100024505 Bone morphogenetic protein 4 Human genes 0.000 claims abstract description 4
- 102100022526 Bone morphogenetic protein 5 Human genes 0.000 claims abstract description 4
- 102100022525 Bone morphogenetic protein 6 Human genes 0.000 claims abstract description 4
- 102100022545 Bone morphogenetic protein 8B Human genes 0.000 claims abstract description 4
- 101000899368 Homo sapiens Bone morphogenetic protein 8B Proteins 0.000 claims abstract description 3
- 229920002988 biodegradable polymer Polymers 0.000 claims description 35
- 239000004621 biodegradable polymer Substances 0.000 claims description 35
- 241000588724 Escherichia coli Species 0.000 claims description 18
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 241000894006 Bacteria Species 0.000 abstract 3
- 239000000126 substance Substances 0.000 abstract 1
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 25
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 25
- 229940112869 bone morphogenetic protein Drugs 0.000 description 25
- 210000000988 bone and bone Anatomy 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 9
- 229920001577 copolymer Polymers 0.000 description 9
- 230000007547 defect Effects 0.000 description 6
- 238000004108 freeze drying Methods 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 210000004962 mammalian cell Anatomy 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 230000011164 ossification Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 229920003232 aliphatic polyester Polymers 0.000 description 2
- 230000010478 bone regeneration Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000008055 phosphate buffer solution Substances 0.000 description 2
- 238000004080 punching Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- VSKXVGWORBZZDY-UHFFFAOYSA-N 2-hydroxypropanoic acid;oxepan-2-one Chemical compound CC(O)C(O)=O.O=C1CCCCCO1 VSKXVGWORBZZDY-UHFFFAOYSA-N 0.000 description 1
- 208000018084 Bone neoplasm Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037237 body shape Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 230000002188 osteogenic effect Effects 0.000 description 1
- 230000002138 osteoinductive effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 description 1
- 229920001610 polycaprolactone Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Abstract
【解決手段】 大腸菌由来のBMPを含んだシート状の生分解性高分子材料から成る人工骨膜とする。このとき、大腸菌由来のBMPが、宿主細胞として大腸菌を用いて生産したBMPであり、BMP-2, BMP-4, BMP-5, BMP-6, BMP-7(OP-1),BMP-8(OP-2),及びこれらの機能的等価改変体(改変型BMP)からなる群より選択されるBMPの1種または2種以上であることが好ましい。
【選択図】 なし
Description
即ち本発明は、大腸菌由来のBMPを含んだシート状の生分解性高分子材料からなる人工骨膜である。
1,4−ジオキサン中に乳酸−グリコール酸共重合体(乳酸:グリコール酸=75:25、分子量約250、000)を8重量%の濃度となるように入れ撹拌器で1時間撹拌させて溶解した。溶解液を100mm×100mm、隙間2mmの型に流し込み、24時間凍結後、48時間真空乾燥させて80mm×80mm、厚み約1mmの生分解性高分子材料を得た。得られた生分解性高分子材料を金属製のプレス型にて300kgf/cm2の条件にて厚さ約0.25mmにプレスした。作製されたシート状の生分解性高分子材料は、孔のサイズが50μm、気孔率50%、厚さが0.25mmであった。
その後、シート状生分解性高分子材料を10mm×10mmの大きさにカットし、濃度1,5,10μg/μLで調製した大腸菌由来BMP-2を溶解させたリン酸緩衝液0.1mL中に4℃で24時間浸漬させた後、取り出し、凍結乾燥させることで人工骨膜を作製した。なお、凍結乾燥前後の重量測定を行ったところ、本実施例の人工骨膜にはそれぞれ、約16,80,160μgの大腸菌由来BMP-2が含まれていた。
1,4−ジオキサン中に乳酸−グリコール酸共重合体(乳酸:グリコール酸=75:25、分子量約250、000)を8重量%の濃度となるように入れ撹拌器で1時間撹拌させて溶解した。溶解液を100mm×100mm、隙間2mmの型に流し込み、24時間凍結後、48時間真空乾燥させて80mm×80mm、厚み約1mmの生分解性高分子材料を得た。得られた生分解性高分子材料を隙間約0.25mmの金属製のプレス型にて300kgf/cm2の条件にて厚さ約0.25mmにプレスした。作製されたシート状の生分解性高分子材料は、孔のサイズが50μm、気孔率50%、厚さが0.25mmであった。
その後、シート状生分解性高分子材料を10mm×10mmの大きさにカットし、濃度1,5,10μg/μLで調製した哺乳動物細胞を利用したBMP-2を溶解させたリン酸緩衝液0.1mL中に4℃で24時間浸漬させた後、取り出し、凍結乾燥させることで人工骨膜を作製した。なお、凍結乾燥前後の重量測定を行ったところ、本実施例の人工骨膜にはそれぞれ、約16,80,160μgの哺乳動物細胞を利用したBMP-2が含まれていた。
哺乳動物由来BMP-2の製造コスト:¥10,000/mg
Claims (4)
- 大腸菌由来のBMPを含んだシート状の生分解性高分子材料から成る人工骨膜。
- 大腸菌由来のBMPが、宿主細胞として大腸菌を用いて生産したBMPであり、BMP-2, BMP-4, BMP-5, BMP-6, BMP-7(OP-1),BMP-8(OP-2),及びこれらの機能的等価改変体(改変型BMP)からなる群より選択されるBMPの1種または2種以上である請求項1に記載の人工骨膜。
- 大腸菌由来のBMPが溶解された水溶液にシート状の生分解性高分子材料を浸漬させた後、取り出して凍結乾燥させる人工骨膜の作製方法。
- 大腸菌由来のBMPが、宿主細胞として大腸菌を用いて生産したBMPであり、BMP-2, BMP-4, BMP-5, BMP-6, BMP-7(OP-1),MP-8(OP-2),及びこれらの機能的等価改変体(改変型BMP)からなる群より選択されるBMPの1種または2種以上である請求項3に記載の人工骨膜の作製方法。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011113498A JP5924610B2 (ja) | 2011-05-20 | 2011-05-20 | 人工骨膜の作製方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011113498A JP5924610B2 (ja) | 2011-05-20 | 2011-05-20 | 人工骨膜の作製方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2012239697A true JP2012239697A (ja) | 2012-12-10 |
JP5924610B2 JP5924610B2 (ja) | 2016-05-25 |
Family
ID=47462047
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011113498A Active JP5924610B2 (ja) | 2011-05-20 | 2011-05-20 | 人工骨膜の作製方法 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5924610B2 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2022500157A (ja) * | 2018-09-14 | 2022-01-04 | オーソセル・リミテッド | 人工骨膜 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH053913A (ja) * | 1991-06-26 | 1993-01-14 | Sumitomo Cement Co Ltd | 人工生体複合材料 |
WO1996010426A1 (fr) * | 1994-09-30 | 1996-04-11 | Yamanouchi Pharmaceutical Co., Ltd. | Greffon osteoplastique |
JP2002502822A (ja) * | 1998-02-10 | 2002-01-29 | オレゴン ヘルス サイエンシーズ ユニバーシティー | 骨芽細胞の前駆細胞による骨欠損の治療 |
JP2003275294A (ja) * | 2002-03-25 | 2003-09-30 | Olympus Optical Co Ltd | 骨再生シート |
US20060045902A1 (en) * | 2004-09-01 | 2006-03-02 | Serbousek Jon C | Polymeric wrap for in vivo delivery of osteoinductive formulations |
JP2007332106A (ja) * | 2006-06-16 | 2007-12-27 | Okayama Univ | 骨形成用徐放性医薬組成物 |
JP2009045142A (ja) * | 2007-08-16 | 2009-03-05 | Okayama Univ | 生体内にて基材周囲に骨形成を誘導するための基材処理方法 |
WO2009129631A1 (en) * | 2008-04-21 | 2009-10-29 | Ao Technology Ag | Biocompatible implant |
JP2010500905A (ja) * | 2006-08-17 | 2010-01-14 | ウォーソー・オーソペディック・インコーポレーテッド | 組織再生に有用な医療インプラントシート |
-
2011
- 2011-05-20 JP JP2011113498A patent/JP5924610B2/ja active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH053913A (ja) * | 1991-06-26 | 1993-01-14 | Sumitomo Cement Co Ltd | 人工生体複合材料 |
WO1996010426A1 (fr) * | 1994-09-30 | 1996-04-11 | Yamanouchi Pharmaceutical Co., Ltd. | Greffon osteoplastique |
JP2002502822A (ja) * | 1998-02-10 | 2002-01-29 | オレゴン ヘルス サイエンシーズ ユニバーシティー | 骨芽細胞の前駆細胞による骨欠損の治療 |
JP2003275294A (ja) * | 2002-03-25 | 2003-09-30 | Olympus Optical Co Ltd | 骨再生シート |
US20060045902A1 (en) * | 2004-09-01 | 2006-03-02 | Serbousek Jon C | Polymeric wrap for in vivo delivery of osteoinductive formulations |
JP2007332106A (ja) * | 2006-06-16 | 2007-12-27 | Okayama Univ | 骨形成用徐放性医薬組成物 |
JP2010500905A (ja) * | 2006-08-17 | 2010-01-14 | ウォーソー・オーソペディック・インコーポレーテッド | 組織再生に有用な医療インプラントシート |
JP2009045142A (ja) * | 2007-08-16 | 2009-03-05 | Okayama Univ | 生体内にて基材周囲に骨形成を誘導するための基材処理方法 |
WO2009129631A1 (en) * | 2008-04-21 | 2009-10-29 | Ao Technology Ag | Biocompatible implant |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2022500157A (ja) * | 2018-09-14 | 2022-01-04 | オーソセル・リミテッド | 人工骨膜 |
Also Published As
Publication number | Publication date |
---|---|
JP5924610B2 (ja) | 2016-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Jiang et al. | Chitosan–poly (lactide-co-glycolide) microsphere-based scaffolds for bone tissue engineering: In vitro degradation and in vivo bone regeneration studies | |
Wang et al. | In vivo degradation of three-dimensional silk fibroin scaffolds | |
Khang | Handbook of intelligent scaffolds for tissue engineering and regenerative medicine | |
Meinel et al. | Silk implants for the healing of critical size bone defects | |
Wang et al. | Osteoinduction and proliferation of bone-marrow stromal cells in three-dimensional poly (ε-caprolactone)/hydroxyapatite/collagen scaffolds | |
JP4628756B2 (ja) | 組織修復インプラント、その製造方法および組織修復方法 | |
Dormer et al. | Osteochondral interface tissue engineering using macroscopic gradients of bioactive signals | |
AU2008245900B2 (en) | Engineered renal tissue | |
US9138483B2 (en) | Collagen/hydroxyapatite composite scaffold, and process for the production thereof | |
Yoshimi et al. | Self-assembling peptide nanofiber scaffolds, platelet-rich plasma, and mesenchymal stem cells for injectable bone regeneration with tissue engineering | |
Zhou et al. | Improving osteogenesis of three-dimensional porous scaffold based on mineralized recombinant human-like collagen via mussel-inspired polydopamine and effective immobilization of BMP-2-derived peptide | |
Li et al. | Biocompatibility and physicochemical characteristics of poly (Ɛ-caprolactone)/poly (lactide-co-glycolide)/nano-hydroxyapatite composite scaffolds for bone tissue engineering | |
Theodoridis et al. | Hyaline cartilage next generation implants from adipose‐tissue–derived mesenchymal stem cells: Comparative study on 3D‐printed polycaprolactone scaffold patterns | |
Liu et al. | Biomimetic poly (glycerol sebacate)/polycaprolactone blend scaffolds for cartilage tissue engineering | |
Mahdavi et al. | Bioactive glass ceramic nanoparticles-coated poly (l-lactic acid) scaffold improved osteogenic differentiation of adipose stem cells in equine | |
JP2008517660A (ja) | 生物剤を送達する中空かつ多孔質の整形外科用または歯科用のインプラント | |
JP2007007414A (ja) | 多区画配送システム | |
Cai et al. | Electrospun nanofibrous matrix improves the regeneration of dense cortical bone | |
Shumilova et al. | Porous 3D implants of degradable poly‐3‐hydroxybutyrate used to enhance regeneration of rat cranial defect | |
Bochicchio et al. | Electrospun poly (d, l‐lactide)/gelatin/glass‐ceramics tricomponent nanofibrous scaffold for bone tissue engineering | |
Ryu et al. | Osteogenic differentiation of human periosteal-derived cells in a three-dimensional collagen scaffold | |
Shishatskaya et al. | An in vivo study of osteoplastic properties of resorbable poly-3-hydroxybutyrate in models of segmental osteotomy and chronic osteomyelitis | |
Ji et al. | Salvianolic acid B-loaded chitosan/hydroxyapatite scaffolds promotes the repair of segmental bone defect by angiogenesis and osteogenesis | |
Goonoo et al. | Improved multicellular response, biomimetic mineralization, angiogenesis, and reduced foreign body response of modified polydioxanone scaffolds for skeletal tissue regeneration | |
Abazari et al. | Poly (glycerol sebacate) and polyhydroxybutyrate electrospun nanocomposite facilitates osteogenic differentiation of mesenchymal stem cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20140513 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20140519 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20140513 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150428 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20150624 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150727 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20150727 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20151020 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20151221 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20151222 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160315 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160408 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5924610 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |